Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates

Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.16 per share a year ago.